Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
IART — Integra LifeSciences Holdings Corporation
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

OCT 30, 2025
REVENUE
$402.1M -3.3%
NET MARGIN
-1.3% +115.1 PTS
EPS
-$0.07 +98.9%
FREE CASH FLOW
$25.8M +329.4%

No summary has been written for this call yet.